Do we need a new P2Y12 receptor antagonist?

Jean-Sébastien Hulot; Gilles Montalescot

doi:10.1093/eurheartj/ehz862

Journal Articles European Heart Journal Year : 2020

Do we need a new P2Y12 receptor antagonist?

(1, 2) , (3, 4)

1
2
3
4

Jean-Sébastien Hulot

Function : Author
PersonId : 759557
ORCID : 0000-0001-5463-6117
IdRef : 058500391

CIC - HEGP

Paris-Centre de Recherche Cardiovasculaire

Gilles Montalescot

Function : Author
PersonId : 757375
ORCID : 0000-0003-0824-6809
IdRef : 035732725

Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases

Institut de cardiologie [CHU Pitié-Salpêtrière]

Domains

Life Sciences [q-bio]

Gestionnaire HAL 4 Sorbonne Université : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-02964744

Submitted on : Monday, October 12, 2020-4:30:54 PM

Last modification on : Thursday, December 14, 2023-1:50:37 PM

Dates and versions

hal-02964744 , version 1 (12-10-2020)

Identifiers

HAL Id : hal-02964744 , version 1
DOI : 10.1093/eurheartj/ehz862
PUBMED : 31845967

Cite

Jean-Sébastien Hulot, Gilles Montalescot. Do we need a new P2Y12 receptor antagonist?. European Heart Journal, 2020, 41 (33), pp.3141-3143. ⟨10.1093/eurheartj/ehz862⟩. ⟨hal-02964744⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

ICAN SORBONNE-UNIVERSITE SU-MEDECINE UP-SANTE IHU_ICAN

17 View

0 Download

Do we need a new P2Y12 receptor antagonist?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share